Skip to main content
. Author manuscript; available in PMC: 2012 Mar 30.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 5;35(2):315–319. doi: 10.1016/j.pnpbp.2010.07.032

Figure 1.

Figure 1

Putative mechanisms linking 5-LOX and COX pathways to Alzheimer’s disease (AD). 5-LOX could influence AD by producing pro-inflammatory leukotrienes (LTB4 and CysLTs) and anti-inflammatory lipoxins (naturally occurring LHA4 and aspirin-triggered 15-epi-LXA4) and by an interaction with the gamma-secretase complex. Cyclooxygenases could influence AD by acting on arachidonic acid (AA) and producing PGH2 and PGE2 (see text for details).